MedPath

Effect Of Topical Aerosolized Ropivacaine(0.75%)on Response To Extubation

Phase 1
Active, not recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2020/07/026563
Lead Sponsor
DrNaresh Yerne
Brief Summary

Ropivacaine has long-acting local anaesthetic and topical anaesthesia wit

The ropivacaine been has reported to significantly attenuate histamine-induced.topical of ropivacaine(nebulisation, infiltration, atomization) reported to significantly reduce extubation response in a hypertensive patient.

We will hypothesize that topical application inhibiting bit hemodynamic response cough reflex during extubation in operative patient under general anaesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
90
Inclusion Criteria

ASA PS I or II schedule, for elective surgery under general anaesthesia requiring oral endotracheal intubation with the clinically normal airway.

Exclusion Criteria
  • Severe cardiovascular, liver, and kidney disfunction; Allergies to amide local anesthetics; Patient with history of risk factor for perioperative aspiration of gastric ontents Difficult airway or history of maxillofacial and neck surgery; Chronic respiratory disease such as chronic obstructive pulmonary disease or asthma, recent respiratory tract infection, chronic cough, and current smoking.
  • Patients with reoperation because of serious adverse events such as bleeding, Anesthesia time more than 4 h, and delayed extubation (more than 1 h without extubation) Prolong surgery (more than 3 hr) Transferd to the Intensive Care Unit (ICU) with the tube were eliminated.
  • Medications invoving angiotensin converting enzyme inhibitor Refusal to participate in study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Hemodynamic response(Mean arterial pressure & HeartRate)toextubation;Will be assesed at extubation | After 2 min | After 5 min
&Will be assesed at extubation | After 2 min | After 5 min
2.Cough occurring at extubation.Will be assesed at extubation | After 2 min | After 5 min
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

OTE, 1st floarGovernment Medical college and Hospital ;Nagpur

🇮🇳

Nagpur, MAHARASHTRA, India

OTE, 1st floarGovernment Medical college and Hospital ;Nagpur
🇮🇳Nagpur, MAHARASHTRA, India
Naresh
Principal investigator
9404212734
dr.naresh08@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.